Tenderwize
Zurück zur Suche

Non-exclusive discount agreement for dexamethasone

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 672 days left·Open·Supplies·Framework
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Dexamethason (ATC-Code: H02AB02).

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

40 / 100

Komplexität

20 / 100

Risikofaktoren

No minimum volume or revenue guarantee; discount agreements may not lead to significant sales if pharmacists prefer oth...

Paper submission required; missing electronic submission may cause delays or errors.

No procurement documents available

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Provision of dexamethasone (ATC H02AB02) finished medicinal products for medical practice supply in Lower Saxony
  • Non-exclusive discount agreement under § 130a Abs. 8 SGB V
Vollständige Zusammenfassung anzeigen

This is an open-house model non-exclusive discount agreement for dexamethasone (ATC H02AB02) as part of the medical practice supply in Lower Saxony, Germany. The contracting body is AOK Niedersachsen, acting via the ARGE-SSB. The contract runs from 01.09.2026 to 31.08.2028, with the possibility to join at any time on the first of a month. No selection is performed; all qualifying pharmaceutical entrepreneurs can participate under identical terms. The tender explicitly states it is not a public procurement procedure under EU directives but is published for transparency. Electronic submission is not allowed.

Risiken

No minimum volume or revenue guarantee; discount agreements may not lead to significant sales if pharmacists prefer oth...

Paper submission required; missing electronic submission may cause delays or errors.

No procurement documents available

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG
  • Agreement is non-exclusive and open to all qualified market participants
  • First joining deadline: 28.07.2026 for start on 01.09.2026

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0000

Non-exclusive discount agreement for dexamethasone

Open-house model for all pharmaceutical entrepreneurs to conclude a discount agreement for dexamethasone (ATC H02AB02) for medical practice supply in Lower Saxony. Contract duration max 24 months, earliest start 01.09.2026, latest end 31.08.2028. Joining possible on the first of each month with 35 calendar days lead time. No selection or negotiation.

SuppliesFrameworkEU fundedElectronic submission

Ort

DE929, Germany

Dauer

Aug 2026 - Aug 2028

Kategorie

Pharmaceutical products

Frist

Deadline Jun 27, 2028

Vergabedetails

Veröffentlichungsdatum
05 Jul 2026
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
461062-2026

Ähnliche Ausschreibungen